| Ident. | Authors (with country if any) | Title |
|---|
| 000174 (2011) |
M. Matinolli [Finlande] ; J. T. Korpelainen [Finlande] ; K. A. Sotaniemi [Finlande] ; V. V. Myllyl [Finlande] ; R. Korpelainen [Finlande] | Recurrent falls and mortality in Parkinson’s disease: a prospective two‐year follow‐up study |
| 000212 (2011) |
Farzaneh Ghazavi [Iran] ; Zeinab Fazlali [Iran] ; Setareh Sadat Banihosseini [Iran] ; Sayed-Rzgar Hosseini [Iran] ; Mohammad Hossein Kazemi [Iran] ; Seyedmehdi Shojaee [Iran] ; Khosro Parsa [Iran] ; Homa Sadeghi [Iran] ; Farzad Sina [Iran] ; Mohammad Rohani [Iran] ; Gholam-Ali Shahidi [Iran] ; Nasser Ghaemi [Iran] ; Mostafa Ronaghi [États-Unis] ; Elahe Elahi [Iran] | PRKN, DJ‐1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ‐1 mutations |
| 000216 (2011) |
Angela Scheuerle [États-Unis] ; Kathleen Wilson [États-Unis] | PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome |
| 000803 (2010) |
F. Hu ; J. Xi ; J. Guo ; L. Yu ; L. Liu ; X. He ; Z. Liu [République populaire de Chine] ; X. Zou ; Y. Xu | Association of the glucocerebrosidase N370S allele with Parkinson’s disease in two separate Chinese Han populations of mainland China |
| 000922 (2009) |
Han-Joon Kim [Corée du Sud] ; Sun Ha Paek [Corée du Sud] ; Ji-Young Kim [Corée du Sud] ; Jee-Young Lee [Corée du Sud] ; Yong Hoon Lim [Corée du Sud] ; Dong Gyu Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud] | Two‐year follow‐up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease |
| 000967 (2009) |
Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Arnulf [France] | Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations |
| 000974 (2009) |
Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie] | Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: A comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training |
| 000B80 (2009) |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
| 000C32 (2008) |
John F. Staropoli [États-Unis] | Tumorigenesis and neurodegeneration: two sides of the same coin? |
| 000C40 (2008) |
Konstanze F. Winklhofer [Allemagne] ; Jörg Tatzelt [Allemagne] ; Christian Haass [Allemagne] | The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases |
| 000C76 (2008) |
Pablo Martinez-Martin [Espagne] ; Martine Visser [Pays-Bas] ; Carmen Rodriguez-Blazquez [Espagne] ; Johan Marinus [Pays-Bas] ; K. Ray Chaudhuri [Royaume-Uni] ; Jacobus J. Van Hilten [Pays-Bas] | SCOPA‐sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease |
| 000C79 (2008) |
Genevieve Bureau [Canada] ; Fanny Longpré [Canada] ; M. Martinoli [Canada] | Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation |
| 000C85 (2008) |
Elena Sinforiani [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Chiara Pasotti [Italie] ; Raffaele Manni [Italie] ; Giuseppe Nappi [Italie] | REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two‐year follow up |
| 000D39 (2008) |
Horng-Huei Liou [Taïwan] ; Chia-Yun Wu [Taïwan] ; Yueh-Hsia Chiu [Taïwan] ; Amy Ming-Fang Yen [Taïwan] ; Rong-Chi Chen [Taïwan] ; Ta-Fu Chen [Taïwan] ; Chih-Chuan Chen [Taïwan] ; Yuarn-Chung Hwang [Taïwan] ; Ying-Rong Wen [Taïwan] ; Tony Hsiu-Hsi Chen [Taïwan] | Natural history and effectiveness of early detection of Parkinson’s disease: results from two community‐based programmes in Taiwan (KCIS no. 11) |
| 000E36 (2008) |
Tricia A. Thornton-Wells [États-Unis] ; Jason H. Moore [États-Unis] ; Eden R. Martin [États-Unis] ; Margaret A. Pericak-Vance [États-Unis] ; Jonathan L. Haines [États-Unis] | Confronting complexity in late‐onset Alzheimer disease: application of two‐stage analysis approach addressing heterogeneity and epistasis |
| 000F58 (2007) |
G. Xiromerisiou [Grèce, États-Unis] ; G. M. Hadjigeorgiou [Grèce] ; V. Gourbali [Grèce] ; J. Johnson [États-Unis] ; I. Papakonstantinou [Grèce] ; A. Papadimitriou [Grèce] ; A. B. Singleton [États-Unis] | Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants |
| 001026 (2007) |
Osamu Yokota ; Kuniaki Tsuchiya ; Toshiki Uchihara ; Hiroshi Ujike ; Seishi Terada ; Mafuyu Takahashi ; Yuji Kimura ; Hideki Ishizu [Japon] ; Haruhiko Akiyama ; Shigetoshi Kuroda | Lewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem |
| 001239 (2006) |
François Sellal [France] | Parkinson's disease with dementia and dementia with Lewy body disease: two syndromes, the same disease? |
| 001278 (2006) |
Wendy R. Galpern [Canada] ; Anthony E. Lang [Canada, États-Unis] | Interface between tauopathies and synucleinopathies: A tale of two proteins |
| 001318 (2006) |
C. Vossius [Norvège] ; M. Gjerstad [Norvège] ; H. Baas [Allemagne] ; J. P. Larsen [Norvège] | Drug costs for patients with Parkinson's disease in two different European countries |
| 001513 (2005) |
Jordi Clarimon [États-Unis] ; Janel Johnson [États-Unis] ; Okan Dogu [Turquie] ; Wagner Horta [Brésil] ; Naheed Khan [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [États-Unis] ; Andrew Singleton [États-Unis] | Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease |
